Evaluation of Oxidative Stress and Effect of Levothyroxine Treatment on Oxidative Stress in Hashimoto Disease
NCT ID: NCT01102205
Last Updated: 2013-06-13
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
130 participants
OBSERVATIONAL
2010-04-30
2010-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effects of Low-Level Laser Therapy on Oxidative Stress Levels
NCT04754607
Effects of Levothyroxine on Endothelial Function of Patients With Subclinical Hypothyroidism
NCT02090907
The Effect of Levothyroxine on Arterial Stiffness and Lipid Profile in Patients With Subclinical Hypothyroidism
NCT00498238
Effects of Levothyroxine Supplementation in Patients With Systolic Heart Failure and Subclinical Hypothyroidism
NCT02316743
Effects of L-carnitine on Hypothyroidism
NCT01769157
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
healthy
No interventions assigned to this group
euthyroid hashimoto
No interventions assigned to this group
hypothyroid hashimoto
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* other conditions and drug usage affect oxidative stress
18 Years
95 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Vakif Gureba Training and Research Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mehmet Ali Cikrikcioglu
Vakif Gureba TRH
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Mehmet ali Cikrikcioglu, MD
Role: STUDY_CHAIR
vakif gureba TRH,fatih,istanbul,turkey.specialist in internal medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Vakif Gureba Training and Research Hospital
Istanbul, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
tastoshashi
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.